{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:47:00Z","timestamp":1793666820329,"version":"4.5.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95806-0","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:29:20Z","timestamp":1743276560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development and evaluation of S-carboxymethyl-L-cystine-loaded solid lipid nanoparticles for Parkinson\u2019s disease in murine and zebrafish models"],"prefix":"10.1038","volume":"15","author":[{"given":"Shannon D","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameera Hammigi","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govardhan Katta","family":"Radhakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golla","family":"Sireesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soundarya","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandral Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavana Gowda","family":"Hosur Dinesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Ganjipete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panneerselvam","family":"Theivendren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarappan","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Kunjiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar Nayak","family":"Ammunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"5","key":"95806_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin, V. L. et al. Global, regional, and National burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 18 (5), 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"issue":"2","key":"95806_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19 (2), 170\u2013178 (2020).","journal-title":"Lancet Neurol."},{"issue":"4","key":"95806_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 79 (4), 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"95806_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","volume":"1184","author":"GM Halliday","year":"2010","unstructured":"Halliday, G. M. & McCann, H. The progression of pathology in Parkinson\u2019s disease. Ann. N. Y. Acad. Sci. 1184 (1), 188\u2013195 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"95806_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fneur.2018.00347","volume":"9","author":"RL Vaz","year":"2018","unstructured":"Vaz, R. L., Outeiro, T. F. & Ferreira, J. J. Zebrafish as an animal model for drug discovery in Parkinson\u2019s disease and other movement disorders: a systematic review. Front. Neurol. 9, 347 (2018).","journal-title":"Front. Neurol."},{"key":"95806_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s12640-017-9778-x","volume":"32","author":"Y Vijayanathan","year":"2017","unstructured":"Vijayanathan, Y. et al. 6-OHDA-lesioned adult zebrafish as a useful Parkinson\u2019s disease model for dopaminergic neuroregeneration. Neurotox. Res. 32, 496\u2013508 (2017).","journal-title":"Neurotox. Res."},{"key":"95806_CR7","doi-asserted-by":"crossref","unstructured":"Robea, M-A. et al. Parkinson\u2019s disease-induced zebrafish models: focussing on oxidative stress implications and sleep processes. Oxidative Medicine and Cellular Longevity. ;2020. (2020).","DOI":"10.1155\/2020\/1370837"},{"key":"95806_CR8","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s12035-016-9919-x","volume":"54","author":"ME Nunes","year":"2017","unstructured":"Nunes, M. E. et al. Chronic treatment with Paraquat induces brain injury, changes in the antioxidant defences system, and modulates behavioural functions in zebrafish. Mol. Neurobiol. 54, 3925\u20133934 (2017).","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"95806_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/03602532.2011.631015","volume":"44","author":"SC Mitchell","year":"2012","unstructured":"Mitchell, S. C. & Steventon, G. B. S-carboxymethyl-L-cysteine. Drug Metab. Rev. 44 (2), 129\u2013147 (2012).","journal-title":"Drug Metab. Rev."},{"key":"95806_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-3-0348-8874-5_6","volume-title":"Rheological properties and hydration of airway mucus. Airway Mucus: Basic Mechanisms and Clinical Perspectives","author":"GJ Phillips","year":"1997","unstructured":"Phillips, G. J., James, S. L. & Lethem, M. I. Rheological properties and hydration of airway mucus. Airway Mucus: Basic Mechanisms and Clinical Perspectives 117\u2013147 (Springer, 1997)."},{"key":"95806_CR11","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre, B., Barayeu, U., Ezeri\u0146a, D. & Dick, T. P. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulphur species. Pharmacol. Ther. 228, 107916 (2021).","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"95806_CR12","first-page":"20","volume":"14","author":"L Brandolini","year":"2003","unstructured":"Brandolini, L. et al. Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur. Cytokine Netw. 14 (1), 20\u201326 (2003).","journal-title":"Eur. Cytokine Netw."},{"issue":"4","key":"95806_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2478\/v10007-012-0040-z","volume":"62","author":"C Pardeshi","year":"2012","unstructured":"Pardeshi, C. et al. Solid lipid-based Nanocarriers: an overview\/nanonosa\u010di Na Bazi \u010cvrstih lipids: pregled. Acta Pharm. 62 (4), 433\u2013472 (2012).","journal-title":"Acta Pharm."},{"issue":"1","key":"95806_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-019-0001-1","volume":"5","author":"S Brito Raj","year":"2019","unstructured":"Brito Raj, S., Chandrasekhar, K. B. & Reddy, K. B. Formulation, in-vitro and in-vivo Pharmacokinetic evaluation of Simvastatin nanostructured lipid carrier loaded transdermal drug delivery system. Future J. Pharm. Sci. 5 (1), 1\u201314 (2019).","journal-title":"Future J. Pharm. Sci."},{"key":"95806_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","volume":"64","author":"W Mehnert","year":"2012","unstructured":"Mehnert, W. & M\u00e4der, K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 64, 83\u2013101 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"95806_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","volume":"127","author":"IP Kaur","year":"2008","unstructured":"Kaur, I. P., Bhandari, R., Bhandari, S. & Kakkar, V. Potential of solid lipid nanoparticles in brain targeting. J. Controlled Release. 127 (2), 97\u2013109 (2008).","journal-title":"J. Controlled Release"},{"key":"95806_CR17","doi-asserted-by":"crossref","unstructured":"Safran, M. et al. GeneCards Version 3: the human gene integrator. Database. ;2010. (2010).","DOI":"10.1093\/database\/baq020"},{"key":"95806_CR18","doi-asserted-by":"crossref","unstructured":"Huang, B., Xiong, J., Zhao, X., Zheng, Y. & Zhu, N. Network pharmacology-based analysis of the pharmacological mechanisms of aloperine on cardiovascular disease. Evidence-Based Complementary and Alternative Medicine. ;2020. (2020).","DOI":"10.1155\/2020\/5180716"},{"issue":"W1","key":"95806_CR19","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. G: profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47 (W1), W191\u2013W8 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"95806_CR20","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36 (8), 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"issue":"5","key":"95806_CR21","doi-asserted-by":"publisher","first-page":"bbab108","DOI":"10.1093\/bib\/bbab108","volume":"22","author":"A Jia","year":"2021","unstructured":"Jia, A., Xu, L. & Wang, Y. Venn diagrams in bioinformatics. Brief. Bioinform. 22 (5), bbab108 (2021).","journal-title":"Brief. Bioinform."},{"key":"95806_CR22","volume-title":"Graph Theoretical analysis, in silico modelling and molecular dynamic studies of (5-((2-chloropyridin-4-yl) oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N, N-dimethylethen-1-amine derivatives for the treatment of breast cancer","author":"T Panneerselvam","year":"2022","unstructured":"Panneerselvam, T. et al. Graph Theoretical analysis, in silico modelling and molecular dynamic studies of (5-((2-chloropyridin-4-yl) oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N, N-dimethylethen-1-amine derivatives for the treatment of breast cancer (Anti-cancer Agents in Medicinal Chemistry, 2022)."},{"issue":"1","key":"95806_CR23","doi-asserted-by":"publisher","first-page":"21488","DOI":"10.1038\/s41598-021-01008-9","volume":"11","author":"AK Kalimuthu","year":"2021","unstructured":"Kalimuthu, A. K. et al. Pharmacoinformatics-based investigation of bioactive compounds of Rasam (South Indian recipe) against human cancer. Sci. Rep. 11 (1), 21488 (2021).","journal-title":"Sci. Rep."},{"issue":"4","key":"95806_CR24","doi-asserted-by":"publisher","first-page":"045012","DOI":"10.1088\/1748-605X\/aabcea","volume":"13","author":"S Kunjiappan","year":"2018","unstructured":"Kunjiappan, S. et al. Design, graph theoretical analysis and in Silico modelling of Dunaliella Bardawil biomass encapsulated keratin nanoparticles: a scaffold for effective glucose utilization. Biomed. Mater. 13 (4), 045012 (2018).","journal-title":"Biomed. Mater."},{"key":"95806_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s11095-007-9234-3","volume":"24","author":"R Asasutjarit","year":"2007","unstructured":"Asasutjarit, R. et al. Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection. Pharm. Res. 24, 1098\u20131107 (2007).","journal-title":"Pharm. Res."},{"key":"95806_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","volume":"10","author":"G Abdelbary","year":"2009","unstructured":"Abdelbary, G. & Fahmy, R. H. Diazepam-loaded solid lipid nanoparticles: design and characterization. Aaps Pharmscitech. 10, 211\u2013219 (2009).","journal-title":"Aaps Pharmscitech"},{"key":"95806_CR27","first-page":"110184","volume":"106","author":"R Kumar","year":"2020","unstructured":"Kumar, R. et al. Preparation, characterization and vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles\u2014Materials. Sci. Engineering: C. 106, 110184 (2020).","journal-title":"Sci. Engineering: C"},{"key":"95806_CR28","doi-asserted-by":"publisher","DOI":"10.1787\/9789264070943-en","volume-title":"Test no. 420: acute oral toxicity\u2014fixed dose procedure","author":"OECD","year":"2002","unstructured":"OECD. Test no. 420: acute oral toxicity\u2014fixed dose procedure (Organization for Economic Co-Operation and Development Paris, France, 2002)."},{"key":"95806_CR29","unstructured":"No, O. T. 203: Fish, acute toxicity test. OECD guidelines for the testing of chemicals, Section. ;2:02\u201324. (1992)."},{"issue":"8","key":"95806_CR30","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/bjp.2008.345","volume":"155","author":"SF Chen","year":"2008","unstructured":"Chen, S. F., Hsu, C. W., Huang, W. H. & Wang, J. Y. Post-injury Baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br. J. Pharmacol. 155 (8), 1279\u20131296 (2008).","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"95806_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/01616412.2017.1352185","volume":"39","author":"Z Hadadianpour","year":"2017","unstructured":"Hadadianpour, Z. et al. The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson\u2019s disease. Neurol. Res. 39 (9), 845\u2013851 (2017).","journal-title":"Neurol. Res."},{"key":"95806_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neures.2017.04.012","volume":"123","author":"H Kuniishi","year":"2017","unstructured":"Kuniishi, H. et al. Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats. Neurosci. Res. 123, 27\u201335 (2017).","journal-title":"Neurosci. Res."},{"issue":"2","key":"95806_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa, H., Ohishi, N. & Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (2), 351\u2013358 (1979).","journal-title":"Anal. Biochem."},{"key":"95806_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/B978-0-12-091302-2.50032-3","volume-title":"Catalase. Methods of enzymatic analysis","author":"H Aebi","year":"1974","unstructured":"Aebi, H. Catalase. Methods of enzymatic analysis 673\u2013684 (Elsevier, 1974)."},{"key":"95806_CR35","volume-title":"Metabolic Conjugation and Metabolic Hydrolysis: Volume I","author":"WH Fishman","year":"2014","unstructured":"Fishman, W. H. Metabolic Conjugation and Metabolic Hydrolysis: Volume I (Academic, 2014)."},{"issue":"3","key":"95806_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/bi00648a036","volume":"15","author":"HP Misra","year":"1976","unstructured":"Misra, H. P. & Fridovich, I. The oxidation of phenylhydrazine: superoxide and mechanism. Biochemistry 15 (3), 681\u2013687 (1976).","journal-title":"Biochemistry"},{"issue":"2","key":"95806_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. Jr & Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (2), 88\u201395 (1961).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"95806_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/inventions3010011","volume":"3","author":"G Audira","year":"2018","unstructured":"Audira, G. et al. A simple setup to perform 3D locomotion tracking in zebrafish by using a single camera. Inventions 3 (1), 11 (2018).","journal-title":"Inventions"},{"key":"95806_CR39","doi-asserted-by":"publisher","first-page":"128029","DOI":"10.1016\/j.chemosphere.2020.128029","volume":"263","author":"RD Azevedo","year":"2021","unstructured":"Azevedo, R. D. et al. Effects of Pyriproxyfen on zebrafish brain mitochondria and acetylcholinesterase. Chemosphere 263, 128029 (2021).","journal-title":"Chemosphere"},{"key":"95806_CR40","doi-asserted-by":"publisher","first-page":"104248","DOI":"10.1016\/j.jff.2020.104248","volume":"75","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Chen, Y., Zhang, X., Lu, Y. & Chen, H. New insights in intestinal oxidative stress damage and the health intervention effects of nutrients: A review. J. Funct. Foods. 75, 104248 (2020).","journal-title":"J. Funct. Foods."},{"key":"95806_CR41","doi-asserted-by":"publisher","first-page":"111139","DOI":"10.1016\/j.biopha.2020.111139","volume":"134","author":"R Benot-Dominguez","year":"2021","unstructured":"Benot-Dominguez, R. et al. Olive leaf extract impairs mitochondria by pro-oxidant activity in MDA-MB-231 and OVCAR-3 cancer cells. Biomed. Pharmacother. 134, 111139 (2021).","journal-title":"Biomed. Pharmacother."},{"issue":"1\u20133","key":"95806_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0300-483X(96)03392-6","volume":"111","author":"SA McFadden","year":"1996","unstructured":"McFadden, S. A. Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. Toxicology 111 (1\u20133), 43\u201365 (1996).","journal-title":"Toxicology"},{"issue":"10","key":"95806_CR43","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/biomedicines9101467","volume":"9","author":"M Catanesi","year":"2021","unstructured":"Catanesi, M. et al. S-Carboxymethyl cysteine protects against oxidative stress and mitochondrial impairment in a Parkinson\u2019s disease in vitro model. Biomedicines 9 (10), 1467 (2021).","journal-title":"Biomedicines"},{"issue":"1","key":"95806_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/1673-5374.224380","volume":"13","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson\u2019s disease model rats. Neural Regeneration Res. 13 (1), 112 (2018).","journal-title":"Neural Regeneration Res."},{"key":"95806_CR45","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s12035-016-0028-7","volume":"54","author":"HE Michel","year":"2017","unstructured":"Michel, H. E., Tadros, M. G., Esmat, A., Khalifa, A. E. & Abdel-Tawab, A. M. Tetramethylpyrazine ameliorates rotenone-induced Parkinson\u2019s disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions. Mol. Neurobiol. 54, 4866\u20134878 (2017).","journal-title":"Mol. Neurobiol."},{"key":"95806_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuint.2018.02.010","volume":"116","author":"S Sharma","year":"2018","unstructured":"Sharma, S., Kumar, P. & Deshmukh, R. Neuroprotective potential of spermidine against rotenone-induced Parkinson\u2019s disease in rats. Neurochem. Int. 116, 104\u2013111 (2018).","journal-title":"Neurochem. Int."},{"issue":"6","key":"95806_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/00207454.2019.1698567","volume":"130","author":"\u0130 \u00dcnal","year":"2020","unstructured":"\u00dcnal, \u0130. et al. Neuroprotective effects of mitoquinone and Oleandrin on Parkinson\u2019s disease model in zebrafish. Int. J. Neurosci. 130 (6), 574\u2013582 (2020).","journal-title":"Int. J. Neurosci."},{"issue":"11","key":"95806_CR48","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1021\/acs.chemrestox.2c00150","volume":"35","author":"P Hettiarachchi","year":"2022","unstructured":"Hettiarachchi, P., Niyangoda, S. S., Jarosova, R. & Johnson, M. A. Dopamine release impairments accompany locomotor and cognitive deficiencies in Rotenone-Treated Parkinson\u2019s disease model zebrafish. Chem. Res. Toxicol. 35 (11), 1974\u20131982 (2022).","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"95806_CR49","first-page":"87","volume":"19","author":"B Ma\u2019arif","year":"2022","unstructured":"Ma\u2019arif, B. et al. The effect of ethanol extract of Marsilea crenata Presl. Leaves on rotenone-induced zebrafish locomotor activity. Jurnal Farmasi Sains Dan. Komunitas (JFSK). 19 (2), 87\u201392 (2022).","journal-title":"Jurnal Farmasi Sains Dan. Komunitas (JFSK)"},{"key":"95806_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuro.2016.11.006","volume":"58","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish. Neurotoxicology 58, 103\u2013109 (2017).","journal-title":"Neurotoxicology"},{"key":"95806_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jocn.2019.01.015","volume":"62","author":"\u0130 \u00dcnal","year":"2019","unstructured":"\u00dcnal, \u0130. & Emekli-Alturfan, E. Fishing for Parkinson\u2019s disease: A review of the literature. J. Clin. Neurosci. 62, 1\u20136 (2019).","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"95806_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias, V., Junn, E. & Mouradian, M. M. The role of oxidative stress in Parkinson\u2019s disease. J. Parkinson\u2019s Disease. 3 (4), 461\u2013491 (2013).","journal-title":"J. Parkinson\u2019s Disease"},{"issue":"1","key":"95806_CR53","doi-asserted-by":"publisher","first-page":"e22416","DOI":"10.1002\/jbt.22416","volume":"34","author":"W Hasan","year":"2020","unstructured":"Hasan, W., Kori, R. K., Jain, J., Yadav, R. S. & Jat, D. Neuroprotective effects of mitochondria-targeted Curcumin against rotenone\u2010induced oxidative damage in the cerebellum of mice. J. Biochem. Mol. Toxicol. 34 (1), e22416 (2020).","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"95806_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-3-21","volume":"3","author":"MK Borland","year":"2008","unstructured":"Borland, M. K. et al. Chronic, low-dose rotenone reproduces lewy neurites found in the early stages of Parkinson\u2019s disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol. Neurodegeneration. 3 (1), 1\u201312 (2008).","journal-title":"Mol. Neurodegeneration"},{"key":"95806_CR55","first-page":"e63240","volume":"177","author":"B Burris","year":"2021","unstructured":"Burris, B., Jensen, N. & Mokalled, M. H. Assessment of swim endurance and swim behavior in adult zebrafish. JoVE (Journal Visualized Experiments). 177, e63240 (2021).","journal-title":"JoVE (Journal Visualized Experiments)"},{"issue":"5","key":"95806_CR56","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1471-4159.2008.05463.x","volume":"106","author":"L Flinn","year":"2008","unstructured":"Flinn, L., Bretaud, S., Lo, C., Ingham, P. W. & Bandmann, O. Zebrafish as a new animal model for movement disorders. J. Neurochem. 106 (5), 1991\u20131997 (2008).","journal-title":"J. Neurochem."},{"key":"95806_CR57","doi-asserted-by":"publisher","first-page":"655550","DOI":"10.3389\/fgene.2021.655550","volume":"12","author":"K Razali","year":"2021","unstructured":"Razali, K. et al. The promise of the zebrafish model for Parkinson\u2019s disease: today\u2019s science and tomorrow\u2019s treatment. Front. Genet. 12, 655550 (2021).","journal-title":"Front. Genet."},{"issue":"1","key":"95806_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.870110106","volume":"11","author":"EJ Pappert","year":"1996","unstructured":"Pappert, E. J. et al. Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov. Disorders: Official J. Mov. Disorder Soc. 11 (1), 24\u201326 (1996).","journal-title":"Mov. Disorders: Official J. Mov. Disorder Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95806-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95806-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:11:12Z","timestamp":1743448272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95806-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95806-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental animal procedures were performed after obtaining prior approval from the Institutional Animal Ethical Committee (IAEC Ref No.: XXVII\/MSRFPH\/COL\/PG-05\/13.02.2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"10885"}}